The Impact of Successful Quitting Smoking After Intensive Smoking Cessation Interventions on Morbidity and Mortality Among Smokers With Severe Mental Disorders - A Nationwide Cohort Study From the Danish Smoking Cessation Database

NCT ID: NCT06967636

Last Updated: 2025-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15863 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We evaluate intensive smoking cessation interventions (GSP) on morbidity and mortality in terms of assessing the impact among quitters and non-quitters with severe mental disorders (SMD)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation, Mental Health Disorders, Inequality in Health Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* F20-F29, F30-F39, F60-F69, F10-F16, F18, F19
* Participation in the GSP in Denmark

Exclusion Criteria

* Dual diagnosis (F00-F99 and a co-occurring substance-use disorder (F10-F16, F18, F19)
* \< 18 years
* No consent to follow-up
* No baseline smoking status
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Parker Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sine Holst-Albrechtsen

MD, MSc

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STOPbase

Identifier Type: REGISTRY

Identifier Source: secondary_id

NPR

Identifier Type: REGISTRY

Identifier Source: secondary_id

RCD

Identifier Type: REGISTRY

Identifier Source: secondary_id

2000-54-0013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation in Alcoholics
NCT00963482 COMPLETED NA
Smoking Cessation for Depressed Smokers
NCT00494728 ACTIVE_NOT_RECRUITING PHASE1/PHASE2
Proactive Outreach for Smoking Treatment
NCT04988477 COMPLETED PHASE2
Developing Empowering Smoking Cessation
NCT06602076 NOT_YET_RECRUITING EARLY_PHASE1